NBY (NovaBay Pharmaceuticals Inc.) Net Sales Margin

NovaBay Pharmaceuticals' business is resilient to market volatility due to stable demand for ophthalmological care. The current net profit margin clearly demonstrates financial stability, with the value consolidating at -285.10. Growth is driven by strategic partnerships with e-commerce platforms, while the maturity of the Avenova portfolio is complemented by expansion into the cosmetic skincare segment.
Analytical breakdowns for novabay.com (NBY)

Net profit margin is calculated as the ratio of net income to total revenue. This coefficient determines the portion of every dollar of revenue that remains within the company after covering all operating and financial expenses. For NovaBay Pharmaceuticals (NBY), this metric reflects the dependence of profits on a single brand in the US. The process of diversifying the product portfolio should stabilize the profit margin level. This price action allows for a real-time assessment of the management's cost-control efficiency.